Molidustat

DB15642InvestigationalSmall molecule

Molidustat is under investigation in clinical trial NCT03350321 (A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects).

Mechanism: Pharmacologically active on Prolyl hydroxylase EGLN2, Egl nine homolog 1, and Prolyl hydroxylase EGLN3
Curator reviewed
Formula / weight: C₁₃H₁₄N₈O₂ · 314.309 g/mol (avg)
Code names: BAY 85-3934

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyIJMBOKOTALXLKS-UHFFFAOYSA-NSMILESO=C1N(NC=C1N1C=CN=N1)C1=NC=NC(=C1)N1CCOCC1

Targets

What you can answer from here — as of August 30, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 2 drug categories

9+ReferencesStructured and connected to the statements they support

Which drugs share a target with Molidustat, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.